Niemann-Pick disease: Difference between revisions

	Niemann-Pick disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Niemann-Pick disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Niemann-Pick disease On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
American Roentgen Ray Society Images of Niemann-Pick disease All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Niemann-Pick disease
CDC on Niemann-Pick disease
disease in the news
Blogs on Niemann-Pick disease
Directions to Hospitals Treating Niemann-Pick disease
Risk calculators and risk factors for Niemann-Pick disease

VisualWikitext

Latest revision as of 16:16, 25 July 2016

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Christeen Henen, M.D. [2]

Synonyms and keywords: NPD

Type A Niemann-Pick disease: classical Niemann-Pick disease; Niemann-Pick disease, acute neuronopathic form; sphingomyelin lipidosis; sphingomyelinase deficiency

Type B Niemann-Pick disease: Niemann-Pick disease, adult non-neuronopathic; Niemann-Pick disease, visceral; Niemann-Pick disease, type E

Type C Niemann-Pick disease: Neurovisceral storage disease with vertical supranuclear ophthalmoplegia; Niemann-Pick disease with cholesterol esterification block; Niemann-Pick disease without sphingomyelinase deficiency; Niemann-Pick disease, chronic neuronopathic form; Niemann-Pick disease, subacute juvenile form; Niemann-Pick disease, type D; Nova Scotia Niemann-Pick disease

Diagnosis

Treatment

Case Studies

Case #1

Related Chapters

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
 __NOTOC__
+{{Niemann-Pick disease}}
+'''For patient information click [[Niemann-Pick disease (patient information)|here]]'''
-'''For patient information click [[Niemann-Pick disease (patient information)|here]]'''
+{{CMG}}; {{AE}} {{CH}}
+{{SK}} NPD
+'''Type A Niemann-Pick disease''': classical Niemann-Pick disease; Niemann-Pick disease, acute neuronopathic form; sphingomyelin lipidosis; sphingomyelinase deficiency
+'''Type B Niemann-Pick disease''': Niemann-Pick disease, adult non-neuronopathic; Niemann-Pick disease, visceral; Niemann-Pick disease, type E
-{{Niemann-Pick disease}}
+'''Type C Niemann-Pick disease''': Neurovisceral storage disease with vertical supranuclear ophthalmoplegia; Niemann-Pick disease with cholesterol esterification block; Niemann-Pick disease without sphingomyelinase deficiency; Niemann-Pick disease, chronic neuronopathic form; Niemann-Pick disease, subacute juvenile form; Niemann-Pick disease, type D; Nova Scotia Niemann-Pick disease
-{{CMG}}
 ==[[Niemann-Pick disease overview|Overview]]==
@@ Line 19: / Line 26: @@
 ==[[Niemann-Pick disease epidemiology and demographics|Epidemiology and Demographics]]==
+==[[Niemann-Pick disease risk factors|Risk Factors]]==
+==[[Niemann-Pick disease screening|Screening]]==
 ==[[Niemann-Pick disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 ==Diagnosis==
-[[Niemann-Pick disease history and symptoms| History and Symptoms]] | [[Niemann-Pick disease physical examination | Physical Examination]] | [[Niemann-Pick disease laboratory findings|Laboratory Findings]] | [[Niemann-Pick disease CT|CT]] | [[Niemann-Pick disease other imaging findings|Other Imaging Findings]] | [[Niemann-Pick disease other diagnostic studies|Other Diagnostic Studies]]
+[[Niemann-Pick disease history and symptoms| History and Symptoms]] | [[Niemann-Pick disease physical examination | Physical Examination]] | [[Niemann-Pick disease laboratory findings|Laboratory Findings]] | [[Niemann-Pick disease electrocardiogram|Electrocardiogram]] | [[Niemann-Pick disease x ray|X Ray]] | [[Niemann-Pick disease CT|CT]] | [[Niemann-Pick disease MRI|MRI]] | [[Niemann-Pick disease ultrasound|Ultrasound]] | [[Niemann-Pick disease other imaging findings|Other Imaging Findings]] | [[Niemann-Pick disease other diagnostic studies|Other Diagnostic Studies]]
 ==Treatment==
-[[Niemann-Pick disease medical therapy|Medical Therapy]] | [[Niemann-Pick disease surgery|Surgery]] | [[Niemann-Pick disease primary prevention|Primary Prevention]] | [[Niemann-Pick disease secondary prevention|Secondary Prevention]] | [[Niemann-Pick disease future or investigational therapies|Future or Investigational Therapies]]
+[[Niemann-Pick disease medical therapy|Medical Therapy]] | [[Niemann-Pick disease surgery|Surgery]] | [[Niemann-Pick disease primary prevention|Primary Prevention]] | [[Niemann-Pick disease secondary prevention|Secondary Prevention]] | [[Niemann-Pick disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Niemann-Pick disease future or investigational therapies|Future or Investigational Therapies]]
+==Case Studies==
+[[Niemann-Pick disease case study one|Case #1]]
 ==Related Chapters==
+* [[Lysosomal storage disease]]
+* [[Lipid storage disorders]]
+* [[Gaucher's disease]]
+* [[Tay-Sachs disease]]
+* [[Leukodystrophy]]
+* [[Mucopolysaccharidoses]]
+* [[Hunter syndrome]]
+* [[Hurler disease]]
+* [[Mucolipidoses]]
+[[Category:Endocrinology]]
-<!--
-==Overview==
-'''Niemann-Pick disease''' is an [[autosomal recessive]] disorder affecting [[lipid]] metabolism (the breakdown and use of fats and [[cholesterol]] in the body), in a way which causes harmful amounts of lipids to accumulate in the [[spleen]], [[liver]], [[lungs]], [[bone marrow]], and [[brain]].
-There are three variants of Niemann-Pick disease based on the [[genetics|genetic]] cause and the symptoms exhibited by the patient.
-==Genetics==
-Mutations in the [[NPC1]], [[NPC2]], and [[SMPD1]] [[gene]]s cause Niemann-Pick disease.
-This condition is inherited in an [[autosomal recessive]] pattern, which means two copies of the gene must be altered for a person to be affected by the disorder. Most often, the parents of a child with an autosomal recessive disorder are not affected but are carriers of one copy of the altered gene. If both parents are carriers, there is a 25% chance with each pregnancy for an affected child. [[Genetic counseling]] and [[genetic testing]] is recommended for families who may be carriers of Niemann-Pick.
-[[Image:autorecessive.svg|thumb|200px|left|Autosomal recessive inheritence]]
-==Types==
-===Types A and B===
-Type A Niemann-Pick disease begins during infancy and is characterized by an enlarged liver and spleen ([[hepatosplenomegaly]]), [[failure to thrive]], and progressive deterioration of the [[nervous system]]. Children affected by this condition generally do not survive past early childhood. Niemann-Pick disease, type A occurs more frequently among individuals of Ashkenazi (eastern and central European) Jewish descent than in the general population. The incidence within the Ashkenazi population is approximately 1 in 40,000 people. The incidence for other populations is unknown.
-Type B disease may include signs of hepatosplenomegaly, growth retardation, and problems with lung function including frequent [[lung]] infections. Other signs include blood abnormalities such as abnormal cholesterol and lipid levels, and low numbers of [[blood cell]]s involved in clotting ([[platelets]]).  People affected by this type of Niemann-Pick disease usually survive into adulthood. Niemann-Pick disease, type B occurs in all populations.
-Mutations in the SMPD1 gene cause Niemann-Pick disease, types A and B. This gene carries instructions for cells to produce an enzyme called acid [[sphingomyelinase]]. This enzyme is found in the [[lysosomes]] (compartments that digest and recycle materials in the cell), where it processes lipids such as [[sphingomyelin]]. Mutations in this gene lead to a deficiency of acid sphingomyelinase and the accumulation of sphingomyelin, cholesterol, and other kinds of lipids within the cells and tissues of affected individuals.
-===Type C===
-Type C is characterized by onset in childhood, although infant and adult onsets are possible. Other signs include severe liver disease, breathing difficulties, developmental delay, seizures, increased muscle tone ([[dystonia]]), lack of coordination, problems with feeding, and an inability to move the eyes vertically. People with this disorder can survive into adulthood. The incidence of Niemann-Pick disease, type C is estimated to be 1 in 150,000 people. The disease occurs more frequently in people of French-Acadian descent in Nova Scotia.
-Mutations in either the NPC1 or NPC2 gene cause Niemann-Pick disease, type C. The NPC1 gene produces a [[membrane protein|protein]] that is located in membranes inside the cell and is involved in the movement of cholesterol and lipids within cells. A deficiency of this protein leads to the abnormal build up of lipids and cholesterol within cell membranes. The NPC2 gene produces a protein that binds and transports cholesterol, although its exact function is not fully understood.
-===Biochemical Transport===
-The molecular basis for this disease is extremely complex due to the role that [[endosome]] formation has on affected patients.  Recently, three theories have attempted to explain the buildup of cholesterol in the lysosomes of affected patients of Niemann-Pick Disease Type C due to the malfunction of the protein NPC-1.
-* The contention by Neufel et al is that the buildup of [[mannose 6-phosphate receptor]]s (MPRs) in the late endosome suggests that the retrograde breakdown of cholesterol via the Trans [[Golgi]] Network cannot occur.<ref name="npp">{{cite journal |author=Neufeld EB, Wastney M, Patel S, et al |title=The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo |journal=J. Biol. Chem. |volume=274 |issue=14 |pages=9627-9635 |year=1999 |pmid=10092649 |doi=}}</ref>
-* Another theory suggests that the blockage of retrograde cholesterol breakdown in the late endosome is due to decreased membrane elasticity and thus the return vesicles of cholesterol to the Trans [[Golgi]] Network cannot bud and form.
-The support of these theories has considerable evidence using mutant proteins [[in vitro]] to determine the buildup of [[cholesterol]] in the [[lysosomes]].  Researchers have also discovered that the NPC-1 protein may function as a pump of cholesterol.<ref name="tmp">{{cite journal |author=Davies JP, Chen FW, Ioannou YA |title=Transmembrane molecular pump activity of Niemann-Pick C1 protein |journal=Science |volume=290 |issue=5500 |pages=2295-2298 |year=2000 |pmid=11125140 |doi=10.1126/science.290.5500.2295}}</ref>
-The overall effect of a malfunction in NPC-1 is that low levels or an absence of the protein lead to the abnormal accumulation of lipids and cholesterol in the cells of people with this condition.
-== External links ==
-[http://ghr.nlm.nih.gov The U.S. National Library of Medicine]''
-==References==
-{{reflist|2}}
-{{Metabolic pathology}}
-[[de:Niemann-Pick-Krankheit]]
-[[es:Enfermedad de Niemann-Pick]]
-[[it:Malattia di Niemann-Pick]]
-[[ru:Болезнь Ниманна — Пика]]
-[[fi:Niemann–Pickin tauti]]
-[[zh:尼曼匹克症]]
--->
 [[Category:Neurology]]
-[[Category:Genetic disorders]]
-[[Category:Autosomal recessive disorders]]
-[[Category:Lysosomal storage diseases]]
-[[Category:Mature chapter]]
-[[Category:Disease]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}